Top-News
Metalle u. Bergbau Kanada

BioVaxys Technology News

Aktie
WKN:  A2QE16 ISIN:  CA09076M1014 US-Symbol:  BVAXF
0,0485 €
+0,00 €
0,00%
16.05.24 12:13:20
Handeln Depot/Watchlist
Aktienanzahl *
145,11 Mio.
Marktkapitalisierung *
8,01 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 30.10.2023

BioVaxys Technology News

16.05.24 - PR Newswire
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order PR Newswire
16.05.24 - PR Newswire
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order PR Newswire
02.05.24 - PR Newswire
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update PR Newswire
01.05.24 - PR Newswire
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 PR Newswire
01.05.24 - PR Newswire
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 PR Newswire
01.05.24 - PR Newswire
BIOVAXYS ERNENNT CHRISTOPHER CHERRY ZUM FINANZLEITER
BIOVAXYS ERNENNT CHRISTOPHER CHERRY ZUM FINANZLEITER PR Newswire
30.04.24 - PR Newswire
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER PR Newswire
18.04.24 - PR Newswire
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update PR Newswire
10.04.24 - PR Newswire
BIOVAXYS UND SPAYVAC-FOR-WILDLIFE, INC. KÜNDIGEN DEN START EINES FELDVERSUCHS ZUR GROSS ANGELEGTEN IMMUNOKONTRAZEPTION IN DER KOMMERZIELLEN AQUAKULTURINDUSTRIE AN
BIOVAXYS UND SPAYVAC-​FOR-WILDLIFE, INC. KÜNDIGEN DEN START EINES FELDVERSUCHS ZUR GROSS ANGELEGTEN IMMUNOKONTRAZEPTION IN DER ...
10.04.24 - PR Newswire
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY
BIOVAXYS AND SPAYVAC-​FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-​SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING ...
10.04.24 - PR Newswire
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY
BIOVAXYS AND SPAYVAC-​FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-​SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING ...
04.04.24 - PR Newswire
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update PR Newswire
03.04.24 - PR Newswire
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE PR Newswire
22.03.24 - PR Newswire
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT PR Newswire
21.03.24 - PR Newswire
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update PR Newswire
08.03.24 - PR Newswire
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order PR Newswire
08.03.24 - PR Newswire
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order PR Newswire
07.03.24 - PR Newswire
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update PR Newswire
05.03.24 - PR Newswire
BioVaxys Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications
BioVaxys Announces Allowance of DPX-​Related Patent for Japan and Filing of Additional International Patent Applications PR Newswire
21.02.24 - PR Newswire
Annual Financial Statements Update for the Year Ended October 31, 2023
Annual Financial Statements Update for the Year Ended October 31, 2023 PR Newswire

Newssuche

Videos

newspaper
17.05.24 +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »